We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) traded down 6.7% during mid-day trading on Tuesday ...
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average recommendation of “Buy” ...
We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look ...
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report) today and set a price target of ...
Shares of Soleno Therapeutics (NASDAQ:SLNO) fell by 6.7% after insider selling. Highlights:,Insider transactions have been ...
Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone with FDA approval ...
In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading ...
Three other Bay Area companies — Mirum Therapeutics Inc. (Nasdaq: MIRM), Soleno Therapeutics Inc. (Nasdaq: SLNO) and Exelixis ...
Soleno Therapeutics, Inc. (NASDAQ:SLNO), a biopharmaceutical company focused on developing and commercializing novel therapeutics for rare diseases, has recently achieved a significant milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results